- Home
- APH vs GSK Comparison
APH vs GSK Comparison
Compare APH & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APH
- GSK
- Stock Information
- Founded
- APH 1932
- GSK 1715
- Country
- APH United States
- GSK United Kingdom
- Employees
- APH N/A
- GSK N/A
- Industry
- APH Electrical Products
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- APH Technology
- GSK Health Care
- Exchange
- APH Nasdaq
- GSK Nasdaq
- Market Cap
- APH 84.5B
- GSK 74.6B
- IPO Year
- APH 1991
- GSK N/A
- Fundamental
- Price
- APH $67.60
- GSK $36.64
- Analyst Decision
- APH Buy
- GSK Hold
- Analyst Count
- APH 13
- GSK 4
- Target Price
- APH $79.12
- GSK $47.00
- AVG Volume (30 Days)
- APH 7.7M
- GSK 5.2M
- Earning Date
- APH 01-22-2025
- GSK 02-05-2025
- Dividend Yield
- APH 0.98%
- GSK 4.21%
- EPS Growth
- APH 23.87
- GSK N/A
- EPS
- APH 1.92
- GSK 0.78
- Revenue
- APH $15,222,700,000.00
- GSK $39,280,393,592.00
- Revenue This Year
- APH $20.92
- GSK $6.43
- Revenue Next Year
- APH $9.18
- GSK $5.34
- P/E Ratio
- APH $35.09
- GSK $23.15
- Revenue Growth
- APH 21.25
- GSK 3.46
- 52 Week Low
- APH $53.25
- GSK $31.72
- 52 Week High
- APH $79.39
- GSK $45.93
- Technical
- Relative Strength Index (RSI)
- APH 40.97
- GSK 58.60
- Support Level
- APH $67.99
- GSK $36.35
- Resistance Level
- APH $70.55
- GSK $37.22
- Average True Range (ATR)
- APH 1.63
- GSK 0.62
- MACD
- APH -0.18
- GSK 0.04
- Stochastic Oscillator
- APH 15.74
- GSK 65.58
About APH Amphenol Corporation
Amphenol is a global supplier of connectors, sensors, and interconnect systems. Amphenol holds the second-largest connector market share globally and sells into the end markets of automotive, broadband, commercial air, industrial, IT and data communications, military, mobile devices, and mobile networks. Amphenol is diversified geographically, with operations in 40 countries.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.